Showing results (121-130 of 128) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
The Lancet. Respiratory Medicine|October 26, 2013
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trialLisa Young, Hye-Seung Lee, Yoshikazu Inoue, et al.The European Respiratory Journal|March 9, 2019
Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosisNishant Gupta, Hye-Seung Lee, Lisa R Young, et al.Respiration; International Review of Thoracic Diseases|December 12, 2022
Quantitative Evaluation of Changes in Three-Dimensional CT Density Distributions in Pulmonary Alveolar Proteinosis after GM-CSF InhalationMiku Oda, Kentaro Yamaura, Haruyuki Ishii, et al.The New England Journal of Medicine|September 5, 2019
Inhaled GM-CSF for Pulmonary Alveolar ProteinosisRyushi Tazawa, Takahiro Ueda, Mitsuhiro Abe, et al.The New England Journal of Medicine|March 18, 2011
Efficacy and safety of sirolimus in lymphangioleiomyomatosisFrancis X McCormack, Yoshikazu Inoue, Joel Moss, et al.ERJ Open Research|February 4, 2020
Validation of a new serum granulocyte-macrophage colony-stimulating factor autoantibody testing kitKoh Nakata, Tatsuki Sugi, Keiko Kuroda, et al.Nature Communications|February 16, 2021
Genetic determinants of risk in autoimmune pulmonary alveolar proteinosisSaori Sakaue, Etsuro Yamaguchi, Yoshikazu Inoue, et al.Nature Genetics|January 3, 2025
Blood DNA virome associates with autoimmune diseases and COVID-19Noah Sasa, Shohei Kojima, Rie Koide, et al.Pageof 13